FDA product code SFU: Glucose Range Monitoring System

SFU is the FDA product code for glucose range monitoring system. It is a Class II device, regulated under 21 CFR 862.1359 and reviewed by the Clinical Chemistry panel. FDA has cleared 1 510(k) submission under SFU, 1 in the last five years. The average 510(k) review took 53 days (median 53); 53 days on average over the last three years. 1 De Novo request was granted under it.

Definition

A glucose range monitoring system (GRM) is intended to automatically measure glucose in the body and provide qualitative or semi-quantitative information about glucose levels or trends continuously or frequently. GRM systems are intended to support general user awareness of glucose ranges related to glycemic control. Outputs from GRM systems do not represent quantitative glucose concentration values and GRM systems are not intended to be used for acute medical decision-making, such as insulin dosing or medication adjustment.

Classification

FieldValue
Device nameGlucose Range Monitoring System
Device classClass II
Regulation21 CFR 862.1359
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for SFU

YearClearancesAvg. review days
2026153

Compare with all 510(k) review times · Search every SFU clearance

Top SFU applicants

ApplicantClearancesLatest
Biolinq Incorporated12026-09-18

Most recent SFU clearances

510(k)ApplicantDeviceDecision dateReview days
K262599Biolinq IncorporatedBiolinq Shine Autonomous Time-in-Range Microsensor2026-09-1853

Recalls for SFU devices

FDA recall records list no recalls for product code SFU.

Frequently asked questions

What is FDA product code SFU?

SFU is the FDA product code for glucose range monitoring system. It is a Class II device, regulated under 21 CFR 862.1359 and reviewed by the Clinical Chemistry panel.

What device class is SFU?

Class II, regulation 21 CFR 862.1359. Typical premarket route: 510(k).

How long does a 510(k) take for product code SFU?

Across 1 cleared submissions the average was 53 days from receipt to decision (median 53).

Which companies have the most SFU clearances?

Biolinq Incorporated (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times